| Active ingredient |
Levothyroxine sodium 25 µg–200 µg |
Levothyroxine sodium 25 µg–200 µg |
| Excipients |
Sodium chloride, microcrystalline cellulose, povidone‑K30, magnesium stearate, silica, hypromellose, hypromellose‑phthalate (for enteric‑coated tablets, if any) |
Sodium chloride, microcrystalline cellulose, povidone‑K30, magnesium stearate, silica, lactose (in some strengths) |
| Tablet type |
Plain or enteric‑coated (Euthyrox “Extended‑Release” in some markets) |
Plain (no enteric‑coated version marketed in the U.S.) |
| Dose strengths (U.S.) |
25, 50, 75, 100, 125, 150, 200 µg (tablet) |
25, 50, 75, 100, 125, 150, 200 µg (tablet) |
| Packaging |
30‑tablet or 90‑tablet packs |
30‑tablet or 90‑tablet packs |
| Stability / Storage |
Store at room temperature, protect from moisture and heat |
Store at room temperature, protect from moisture and heat |
| Cost (average retail) |
Generally cheaper than Synthroid in the U.S., but prices vary by pharmacy |
Slightly higher in many U.S. markets (but still typically covered by insurance) |
| Generic availability |
Generic levothyroxine (several manufacturers) |
Generic levothyroxine (several manufacturers) |
| International availability |
Widely available in Europe, Asia, Latin America |
Widely available in Europe, Asia, Latin America; “Synthroid” brand name used mainly in the U.S. |